Publication details
ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ SIOP (14.10.2022 – 14.10.2023)
| Title in English | PROGRESS REPORT ON THE SIOP CLINICAL EVALUATION (14/10/2022 – 14/10/2023) |
|---|---|
| Authors | |
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | SIOP |
| Description | Submission of the Annual Report on the course of the clinical trial of SIOP Ependymoma II for the period from 14 October 2022 to 14 October 2023. SIOP Ependymoma II is an international clinical program for the diagnosis and treatment of children, adolescents, and young adults with ependymoma. SÚKL granted a permit for the clinical trial on 23 February 2017. The clinical trial is taking place in the Czech Republic at The University Hospital Brno (10 included patients so far) and at the Motol University Hospital in Prague (4 patients included so far). The new version of the clinical trial protocol (version 4.0 dated 11.7.2022) was approved by SÚKL on 18/04/2023, the multicentric ethics committee on 10/05/2023 and the local ethics committee on 19/04/2023. |